Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2026 FYStats. 
Home
Equities
MYGN
Chart

Myriad Genetics Inc

MYGN

Jan 1 1970 00:00:00
6.18
▼-0.03000▼-0.48%
6.18
6.24
6.07
6.21
66.52k
-4.10
-1.51
577.88M
93.51M
Chart
Fundamentals
Soon
Sentiment
Soon
Options
Loading...

Recent Filings

2026-03-09
Form 4
ID: 0001738340-26-000002
2026-03-04
EFFECT
ID: 9999999995-26-000727
2026-03-04
Form 424B3
ID: 0000899923-26-000029
2026-03-02
Form 4
ID: 0001472827-26-000002
2026-02-27
Form 4
ID: 0001471518-26-000002
2026-02-24
Form S-3
ID: 0000899923-26-000020
2026-02-24
Form 10-K
ID: 0000899923-26-000018
2026-02-23
Form 8-K
ID: 0000899923-26-000012
2026-02-11
SCHEDULE 13G/A
ID: 0001104659-26-013531
2026-02-09
SCHEDULE 13G
ID: 0000093751-26-000072

You might find these companies interesting

IDXX
Idexx Laboratories Inc /De
In Vitro & In Vivo Diagnostic Substances (2835)
BZYR
Burzynski Research Institute Inc
In Vitro & In Vivo Diagnostic Substances (2835)
NEOG
Neogen Corp
In Vitro & In Vivo Diagnostic Substances (2835)
TKNO
Alpha Teknova, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
BMRA
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances (2835)
TRIB
Trinity Biotech Plc
In Vitro & In Vivo Diagnostic Substances (2835)
CLDX
Celldex Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
VNRX
Volitionrx Ltd
In Vitro & In Vivo Diagnostic Substances (2835)
ICCC
Immucell Corp /De/
In Vitro & In Vivo Diagnostic Substances (2835)
QCLS
Q/c Technologies, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
LNTH
Lantheus Holdings, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
IMDX
Insight Molecular Diagnostics Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
ATNM
Actinium Pharmaceuticals, Inc.
Pharmaceutical Preparations (2834)
PMVP
Pmv Pharmaceuticals, Inc.
Pharmaceutical Preparations (2834)